Sfoglia per Autore
Compulsive-like effects of repeated administration of quinpirole on drinking behavior in rats
2006 Davide, Amato; Milella, MICHELE STANISLAW; Badiani, Aldo; Nencini, Paolo
Compulsive-like effects of quinpirole on drinking behavior in rats are inhibited by substituting ethanol for water
2007 Davide, Amato; Milella, MICHELE STANISLAW; Badiani, Aldo; Nencini, Paolo
Taxanes as primary chemotherapy for early breast cancer. Meta-analysis of randomized trials
2008 Cuppone, F.; Bria, E.; Carlini, P.; Milella, M.; Felici, A.; Sperduti, I.; Nistico, C.; Terzoli, E.; Cognetti, F.; Giannarelli, D.
The influence of cost manipulation on water contrafreeloading induced by repeated exposure to quinpirole in the rat
2008 Milella, MICHELE STANISLAW; Davide, Amato; Badiani, Aldo; Nencini, Paolo
In vivo chronic exposure to heroin or naltrexone selectively inhibits liver microsome formation of estradiol-3-glucuronide in the rat
2008 Antonilli, Letizia; Brusadin, Valentina; Milella, MICHELE STANISLAW; Sobrero, Fabrizia; Badiani, Aldo; Nencini, Paolo
Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors. an important role for mutations in minor clones
2009 Marchetti, Antonio; Milella, Michele; Felicioni, Lara; Cappuzzo, Federico; Irtelli, Luciana; Del Grammastro, Maela; Sciarrotta, Mariagrazia; Malatesta, Sara; Nuzzo, Carmen; Finocchiaro, Giovanna; Perrucci, Bruno; Carlone, Donatella; Gelibter, Alain J; Ceribelli, Anna; Mezzetti, Andrea; Iacobelli, Stefano; Cognetti, Francesco; Buttitta, Fiamma
A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer
2009 Bria, E.; Milella, M.; Sperduti, I.; Alessandrini, G.; Visca, P.; Corzani, F.; Giannarelli, D.; Cerasoli, Virna; Cuppone, F.; Cecere, F. L.; Marchetti, A.; Sacco, R.; Mucilli, F.; Malatesta, S.; Guetti, Leonardo; Vitale, L.; Ceribelli, A.; Rinaldi, M.; Terzoli, E.; Cognetti, F.; Facciolo, F.
Targeting targeted agents. Open issues for clinical trial design
2009 Bria, E.; Di Maio, M.; Carlini, P.; Cuppone, F.; Giannarelli, D.; Cognetti, F.; Milella, M.
Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers
2009 Pino, M. S.; Milella, M.; Gelibter, A.; Sperduti, I.; De Marco, S.; Nuzzo, C.; Bria, E.; Carpanese, Livio; Ruggeri, E. M.; Carlini, P.; Cognetti, F.
Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer? Meta-analysis of randomized trials
2009 Bria, E.; Cuppone, Francesca; Giannarelli, D.; Milella, M.; Ruggeri, E. M.; Sperduti, I.; Pinnaro, P.; Terzoli, E.; Cognetti, F.; Carlini, P.
Clinical significance of PTEN and p-Akt co-expression in HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies
2010 Fabi, A.; Metro, G.; Di Benedetto, A.; Nistico, C.; Vici, P.; Melucci, E.; Antoniani, B.; Perracchio, L.; Sperduti, I.; Milella, M.; Cognetti, F.; Mottolese, M.
Fixed-dose-rate gemcitabine. A viable first-line treatment option for advanced pancreatic and biliary tract cancer
2010 Milella, M.; Gelibter, A. J.; Pino, MARIA SIMONA; Bossone, G.; Marolla, P.; Sperduti, I.; Cognetti, F.
Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: Meta-analysis of randomized clinical trials
2010 Loupakis, F.; Bria, E.; Vaccaro, V.; Cuppone, F.; Milella, M.; Carlini, P.; Cremolini, C.; Salvatore, L.; Falcone, A.; Muti, P.; Sperduti, I.; Giannarelli, D.; Cognetti, F.
Early recurrence risk: Aromatase inhibitors versus tamoxifen
2010 Bria, E.; Carlini, P.; Cuppone, F.; Vaccaro, V.; Milella, M.; Cognetti, F.
Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer. Meta-analysis of randomized trials
2010 Cuppone, F.; Bria, E.; Giannarelli, D.; Vaccaro, V.; Milella, M.; Nistico, C.; Ruggeri, E. M.; Sperduti, I.; Bracarda, S.; Pinnaro, P.; Lanzetta, G.; Muti, P.; Cognetti, F.; Carlini, P.
Opposite roles of dopamine and orexin in quinpirole-induced excessive drinking: a rat model of psychotic polydipsia
2010 Milella, MICHELE STANISLAW; Passarelli, Francesca; DE CAROLIS, Lorenza; Chiara, Schepisi; Paola, Nativio; Scaccianoce, Sergio; Nencini, Paolo
Emerging pathways and future targets for the molecular therapy of pancreatic cancer
2011 Vaccaro, V.; Melisi, D.; Bria, E.; Cuppone, F.; Ciuffreda, L.; Pino, M. S.; Gelibter, A.; Tortora, G.; Cognetti, F.; Milella, M.
Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior.
2011 DE CAROLIS, Lorenza; Chiara, Schepisi; Milella, MICHELE STANISLAW; Nencini, Paolo
Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment. A meta-analysis
2011 Bria, E.; Milella, M.; Cuppone, F.; Novello, Sebastiano; Ceribelli, A.; Vaccaro, V.; Sperduti, I.; Gelibter, A.; Scagliotti, G. V.; Cognetti, F.; Giannarelli, D.
Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients. Meta-regression analysis of randomized trials
2011 Cuppone, F.; Bria, E.; Vaccaro, V.; Puglisi, F.; Fabi, A.; Sperduti, I.; Carlini, P.; Milella, M.; Nistico, C.; Russillo, M.; Papaldo, P.; Ferretti, G.; Aapro, M.; Giannarelli, D.; Cognetti, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Compulsive-like effects of repeated administration of quinpirole on drinking behavior in rats | 2006 | Davide, Amato; Milella, MICHELE STANISLAW; Badiani, Aldo; Nencini, Paolo | |
| Compulsive-like effects of quinpirole on drinking behavior in rats are inhibited by substituting ethanol for water | 2007 | Davide, Amato; Milella, MICHELE STANISLAW; Badiani, Aldo; Nencini, Paolo | |
| Taxanes as primary chemotherapy for early breast cancer. Meta-analysis of randomized trials | 2008 | Cuppone, F.; Bria, E.; Carlini, P.; Milella, M.; Felici, A.; Sperduti, I.; Nistico, C.; Terzoli, E.; Cognetti, F.; Giannarelli, D. | |
| The influence of cost manipulation on water contrafreeloading induced by repeated exposure to quinpirole in the rat | 2008 | Milella, MICHELE STANISLAW; Davide, Amato; Badiani, Aldo; Nencini, Paolo | |
| In vivo chronic exposure to heroin or naltrexone selectively inhibits liver microsome formation of estradiol-3-glucuronide in the rat | 2008 | Antonilli, Letizia; Brusadin, Valentina; Milella, MICHELE STANISLAW; Sobrero, Fabrizia; Badiani, Aldo; Nencini, Paolo | |
| Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors. an important role for mutations in minor clones | 2009 | Marchetti, Antonio; Milella, Michele; Felicioni, Lara; Cappuzzo, Federico; Irtelli, Luciana; Del Grammastro, Maela; Sciarrotta, Mariagrazia; Malatesta, Sara; Nuzzo, Carmen; Finocchiaro, Giovanna; Perrucci, Bruno; Carlone, Donatella; Gelibter, Alain J; Ceribelli, Anna; Mezzetti, Andrea; Iacobelli, Stefano; Cognetti, Francesco; Buttitta, Fiamma | |
| A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer | 2009 | Bria, E.; Milella, M.; Sperduti, I.; Alessandrini, G.; Visca, P.; Corzani, F.; Giannarelli, D.; Cerasoli, Virna; Cuppone, F.; Cecere, F. L.; Marchetti, A.; Sacco, R.; Mucilli, F.; Malatesta, S.; Guetti, Leonardo; Vitale, L.; Ceribelli, A.; Rinaldi, M.; Terzoli, E.; Cognetti, F.; Facciolo, F. | |
| Targeting targeted agents. Open issues for clinical trial design | 2009 | Bria, E.; Di Maio, M.; Carlini, P.; Cuppone, F.; Giannarelli, D.; Cognetti, F.; Milella, M. | |
| Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers | 2009 | Pino, M. S.; Milella, M.; Gelibter, A.; Sperduti, I.; De Marco, S.; Nuzzo, C.; Bria, E.; Carpanese, Livio; Ruggeri, E. M.; Carlini, P.; Cognetti, F. | |
| Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer? Meta-analysis of randomized trials | 2009 | Bria, E.; Cuppone, Francesca; Giannarelli, D.; Milella, M.; Ruggeri, E. M.; Sperduti, I.; Pinnaro, P.; Terzoli, E.; Cognetti, F.; Carlini, P. | |
| Clinical significance of PTEN and p-Akt co-expression in HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies | 2010 | Fabi, A.; Metro, G.; Di Benedetto, A.; Nistico, C.; Vici, P.; Melucci, E.; Antoniani, B.; Perracchio, L.; Sperduti, I.; Milella, M.; Cognetti, F.; Mottolese, M. | |
| Fixed-dose-rate gemcitabine. A viable first-line treatment option for advanced pancreatic and biliary tract cancer | 2010 | Milella, M.; Gelibter, A. J.; Pino, MARIA SIMONA; Bossone, G.; Marolla, P.; Sperduti, I.; Cognetti, F. | |
| Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: Meta-analysis of randomized clinical trials | 2010 | Loupakis, F.; Bria, E.; Vaccaro, V.; Cuppone, F.; Milella, M.; Carlini, P.; Cremolini, C.; Salvatore, L.; Falcone, A.; Muti, P.; Sperduti, I.; Giannarelli, D.; Cognetti, F. | |
| Early recurrence risk: Aromatase inhibitors versus tamoxifen | 2010 | Bria, E.; Carlini, P.; Cuppone, F.; Vaccaro, V.; Milella, M.; Cognetti, F. | |
| Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer. Meta-analysis of randomized trials | 2010 | Cuppone, F.; Bria, E.; Giannarelli, D.; Vaccaro, V.; Milella, M.; Nistico, C.; Ruggeri, E. M.; Sperduti, I.; Bracarda, S.; Pinnaro, P.; Lanzetta, G.; Muti, P.; Cognetti, F.; Carlini, P. | |
| Opposite roles of dopamine and orexin in quinpirole-induced excessive drinking: a rat model of psychotic polydipsia | 2010 | Milella, MICHELE STANISLAW; Passarelli, Francesca; DE CAROLIS, Lorenza; Chiara, Schepisi; Paola, Nativio; Scaccianoce, Sergio; Nencini, Paolo | |
| Emerging pathways and future targets for the molecular therapy of pancreatic cancer | 2011 | Vaccaro, V.; Melisi, D.; Bria, E.; Cuppone, F.; Ciuffreda, L.; Pino, M. S.; Gelibter, A.; Tortora, G.; Cognetti, F.; Milella, M. | |
| Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior. | 2011 | DE CAROLIS, Lorenza; Chiara, Schepisi; Milella, MICHELE STANISLAW; Nencini, Paolo | |
| Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment. A meta-analysis | 2011 | Bria, E.; Milella, M.; Cuppone, F.; Novello, Sebastiano; Ceribelli, A.; Vaccaro, V.; Sperduti, I.; Gelibter, A.; Scagliotti, G. V.; Cognetti, F.; Giannarelli, D. | |
| Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients. Meta-regression analysis of randomized trials | 2011 | Cuppone, F.; Bria, E.; Vaccaro, V.; Puglisi, F.; Fabi, A.; Sperduti, I.; Carlini, P.; Milella, M.; Nistico, C.; Russillo, M.; Papaldo, P.; Ferretti, G.; Aapro, M.; Giannarelli, D.; Cognetti, F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile